Cytokinetics (CYTK)
NASDAQ:CYTK
US Market
Advertisement

Cytokinetics (CYTK) Technical Analysis

Compare
1,185 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Cytokinetics’s (CYTK) Moving Averages Convergence Divergence (MACD) indicator is 2.44, suggesting Cytokinetics is a Sell.
Cytokinetics’s (CYTK) 20-Day exponential moving average is 61.76, while Cytokinetics’s (CYTK) share price is $66.44, making it a Buy.
Cytokinetics’s (CYTK) 50-Day exponential moving average is 56.69, while Cytokinetics’s (CYTK) share price is $66.44, making it a Buy.

Cytokinetics (CYTK) Pivot Points

Nov 16, 2025, 06:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
62.97
63.64
64.58
65.25
66.19
66.86
67.80
Fibonacci
63.64
64.26
64.64
65.25
65.86
66.24
66.86
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cytokinetics (CYTK) Moving Averages

Nov 16, 2025, 06:47 PM
Period
Simple
Exponential
MA5
65.32Buy
65.07Buy
MA10
62.59Buy
63.62Buy
MA20
61.15Buy
61.76Buy
MA50
57.04Buy
56.69Buy
MA100
47.32Buy
51.00Buy
MA200
43.18Buy
47.61Buy
Cytokinetics’s (CYTK) 10-Day exponential moving average is 63.62, while Cytokinetics’s (CYTK) share price is $66.44, making it a Buy.
Cytokinetics’s (CYTK) 100-Day exponential moving average is 51.00, while Cytokinetics’s (CYTK) share price is $66.44, making it a Buy.
Cytokinetics’s (CYTK) stock price is $66.44 and Cytokinetics’s (CYTK) 50-day simple moving average is 57.04, creating a Buy signal.
Cytokinetics’s (CYTK) stock price is $66.44 and Cytokinetics’s (CYTK) 100-day simple moving average is 47.32, creating a Buy signal.
Cytokinetics’s (CYTK) stock price is $66.44 and Cytokinetics’s (CYTK) 200-day simple moving average is 43.18, creating a Buy signal.

Cytokinetics (CYTK) Technical Indicators

Nov 16, 2025, 06:47 PM
Name
Value
Implied Action
RSI (14)
66.80
Neutral
STOCH (9,6)
88.34
Sell
STOCHRSI (14)
88.89
Sell
MACD (12,26)
2.44
Sell
ADX (14)
29.21
Neutral
Williams %R
-6.98
Sell
CCI (14)
136.00
Sell
ATR (14)
2.66
-
Ultimate Oscillator
71.04
Buy
ROC
10.40
Buy
Cytokinetics’s (CYTK) Relative Strength Index (RSI) is 66.80, creating a Neutral signal.
Cytokinetics’s (CYTK) Trend Strength Indicator (ADX) is 29.21, creating a Neutral signal.
Cytokinetics’s (CYTK) Commodity Channel Index (CCI) is 136.00, creating a Sell signal.
Cytokinetics’s (CYTK) Price Rate of Change (ROC) is 10.40, creating a Buy signal.

FAQ

Is CYTK a Buy, Hold, or Sell?
Based on CYTK’s technical indicators, CYTK is a Buy.
    What is CYTK’s RSI (14)?
    CYTK’s RSI (14) is 66.80, which suggests CYTK is a Neutral.
      What is CYTK’s MACD?
      CYTK’s MACD is 2.44, which suggests CYTK is a Sell.
        What is CYTK’s 5-day moving average?
        CYTK’s 5-day moving average is 65.32, which suggests CYTK is a Buy.
          What is CYTK’s 20-day moving average?
          CYTK 20-day moving average is 61.15, which suggests CYTK is a Buy.
            What is CYTK’s 50-day moving average?
            CYTK’s 50-day moving average is 57.04, which suggests CYTK is a Buy.
              What is CYTK’s 200-day moving average?
              CYTK’s 200-day moving average is 43.18, which suggests CYTK is a Buy.
                What is CYTK’s Williams % R (14)?
                CYTK’s Williams % R (14) is -6.98, which suggests CYTK is a Sell.
                  What is CYTK’s CCI (14)?
                  CYTK’s CCI (14) is 136.00, which suggests CYTK is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis